Predicting the Incidence and Prognosis of Bone Metastatic Breast Cancer: A SEER‐Based Observational Study

Abstract

Bone metastasis patients present a more favorable oncological survival consequence than other metastases, and the TNBC subtype with bone metastasis showed the poorest tumor outcome compared with the other three molecular subtypes.